Research Insight

In their just-released Clinical Cancer Advances 2016: ASCO’s Annual Report on Progress Against Cancer the American Society of Clinical Oncology (ASCO) has today hailed cancer immunotherapy as the top cancer advance of the year. “No...

In one of the first studies of its kind, a new report finds a large majority of breast cancers in Cote d’Ivoire and Republic of Congo are detected only after they’ve become advanced. The study, by American Cancer Society...

While cancer is the second leading cause of death overall in the United States, it remains the leading cause of death among U.S. Hispanics. The finding comes from “Cancer Statistics for Hispanics/Latinos,” a comprehensive report produced every three years...

The largest population genome sequencing effort to date is published today in Nature. A series of papers describing resources and application of the data is published at the same time in Nature, Nature Genetics, Bioinformatics and Nature Communications. ...

US-based Amgen has signed a strategic research collaboration and license agreement with Kite Pharma to develop and commercialise chimeric antigen receptor (CAR) T cell immunotherapies. The immunotherapies will be developed based on Kite's engineered autologous cell...

France-based TxCell and Switzerland's Ferring International have partnered with Trizell Holding to further enhance the development of TxCell's Ovasave to treat inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. The collaboration, option, development and...

Swiss drug-maker Novartis has entered collaboration and licensing agreements with Intellia Therapeutics to develop new medicines using CRISPR genome editing technology and Caribou Biosciences for drug discovery tools. CRISPR is an acronym for clustered regularly interspaced...